Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CARM1 | Q86X55 | 4/20 | 0.56 |
| ▸ | PRMT6 | Q96LA8 | 4/20 | 0.56 |
| ▸ | ERCC1 | P07992 | 1/20 | 0.54 |
| ▸ | ERCC4 | Q92889 | 1/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.49 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.48 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.48 |
| ▸ | DRD2 | P14416 | 1/20 | 0.48 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.48 |
| ▸ | DRD1 | P21728 | 1/20 | 0.48 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.48 |
| ▸ | DRD3 | P35462 | 1/20 | 0.48 |
| ▸ | PTGES | O14684 | 1/20 | 0.45 |
| ▸ | SMO | Q99835 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | FAAH | O00519 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23417897 | 0.89 | CARM1 (0.56) | CARM1PRMT6ERCC1ERCC4PTGES | |
| SCHEMBL29344009 | 0.88 | CARM1 (0.49) | CARM1PRMT6ERCC1ERCC4ALOX15 | |
| SCHEMBL26418208 | 0.82 | ERCC1 (0.47) | CARM1PRMT6ERCC1ERCC4ALOX15 | |
| SCHEMBL14368078 | 0.81 | ERCC1 (0.64) | CARM1PRMT6ERCC1ERCC4PTGES | |
| SCHEMBL24668212 | 0.80 | ALOX15 (0.54) | CARM1PRMT6ALOX15ADRB2ADRA2A | |
| SCHEMBL14573639 | 0.79 | ERCC1 (0.60) | CARM1PRMT6ERCC1ERCC4PTGES | |
| SCHEMBL26428983 | 0.77 | ADRB2 (0.50) | CARM1PRMT6ALOX15ADRB2ADRA2A | |
| SCHEMBL22059482 | 0.77 | ERCC1 (0.59) | CARM1PRMT6ERCC1ERCC4PTGES | |
| SCHEMBL26418205 | 0.77 | ERCC1 (0.54) | CARM1PRMT6ERCC1ERCC4MEN1 | |
| SCHEMBL28177057 | 0.75 | CARM1 (0.56) | CARM1PRMT6ERCC1ERCC4ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240238436-A1 | COMPOSITIONS INCLUDING CONJUGATED THERAPY ENHANCERS | BIOHAVEN THERAPEUTICS LTD. (VG) | 2024-07-18 | — | — | US | disclosed |
| US-20230128688-A1 | DIRECTED CONJUGATION TECHNOLOGIES | KLEO PHARMACEUTICALS, INC. | 2023-04-27 | — | — | US | disclosed |
| US-20230128688-A1 | DIRECTED CONJUGATION TECHNOLOGIES | KLEO PHARMACEUTICALS, INC. | 2023-04-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230128688-A1 | DIRECTED CONJUGATION TECHNOLOGIES | CD2BP2, CD2, CD47 | CARM1 802/4885PRMT6 154/4885ERCC1 3649/4885 |
| US-20240238436-A1 | COMPOSITIONS INCLUDING CONJUGATED THERAPY ENHANCERS | LGMN, LPXN, LY96 | CARM1 1110/4885PRMT6 1874/4885ERCC1 4251/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.